A Phase 3 Prospective, Randomized, Double-Blind, Multicenter, Study Of The Efficacy And Safety Of Lanreotide Autogel/ Depot 120Mg Plus Bsc Vs Placebo
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Drug
The purpose of this research study is to evaluate effectiveness and safety of lanreotide for treating neuroendocrine tumors (NET) of the Lungs. In this study, lanreotide will be compared with placebo treatment (i.e. dummy treatment that looks like the real treatment but contains no active ingredient
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Neuroendocrine Tumor Of The Lungs.
Keywords:
A-Us-52030-328, Cancer, Lung, Lung Cancer, Phase I
For More Information:
Uc Cancer Center
(513) 584-7698
kastla@ucmail.uc.edu